Our study aimed to investigate whether monocyte‐to‐albumin ratio (MAR), a novel marker of systemic inflammation, could predict hematoma expansion (HE) in patients with spontaneous intracerebral hemorrhage (ICH). The gene discussed is ALB; the disease is hematoma.